Boston Scientific Corp.(NYSE : BSX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||2.83%||537.72||1.0%||$718.51m|
|ISRG||Intuitive Surgical, Inc.||3.89%||200.89||0.8%||$366.86m|
|BDX||Becton, Dickinson & Co.||1.81%||234.95||1.0%||$273.04m|
|BSX||Boston Scientific Corp.||1.87%||40.63||1.0%||$271.25m|
|EW||Edwards Lifesciences Corp.||2.34%||87.46||0.4%||$247.14m|
|ALGN||Align Technology, Inc.||5.05%||226.53||6.4%||$217.04m|
|A||Agilent Technologies, Inc.||2.59%||129.65||1.7%||$193.62m|
|BAX||Baxter International, Inc.||2.84%||57.20||1.8%||$174.31m|
|STE||STERIS Plc (Ireland)||2.78%||174.79||3.1%||$147.88m|
|SWAV||Shockwave Medical, Inc.||1.78%||283.92||0.0%||$139.00m|
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.